Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.085
-0.055 (-1.75%)
Sep 11, 2026, 4:08 PM HKT

HKG:1066 Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, HKG:1066 stock has a consensus rating of "Strong Buy" and an average price target of $5.38. The average 1-year stock price forecast is 74.39% higher than the current stock price, while the lowest is $3.87 (+25.45%) and the highest is $8.19 (+165.48%).

Price Target: $5.38 (+74.39%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$3.87$5.38$4.85$8.19
Change+25.45%+74.39%+57.21%+165.48%

Analyst Ratings

The average analyst rating for HKG:1066 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy788888
Buy111111
Hold112222
Sell000000
Strong Sell000000
Total91011111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Zhongtai Securities
No rating
Zhongtai Securities
Buy
Maintains
$4.15
BuyMaintains$4.15+34.52%Sep 6, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$5.10
BuyMaintains$5.10+65.32%Sep 1, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$6.00$4.80
BuyMaintains$6.00$4.80+55.59%Aug 27, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$4.80
BuyMaintains$4.80+55.59%Aug 27, 2026
Goldman Sachs
Goldman Sachs
Hold
Maintains
$3.86
HoldMaintains$3.86+25.12%Aug 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
13.81B
from 13.39B
Increased by 3.11%
Revenue Next Year
14.86B
from 13.81B
Increased by 7.64%
EPS This Year
0.33
from 0.36
Decreased by -7.64%
EPS Next Year
0.41
from 0.33
Increased by 25.54%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
13.21B13.75B13.23B13.09B13.39B13.81B
Revenue Growth
13.65%4.08%-3.77%-1.08%2.31%3.11%
Gross Profit
7.34B7.29B6.61B6.54B6.33B6.34B
Gross Margin
55.54%53.05%49.97%49.94%47.26%45.93%
Operating Income
3.00B3.04B2.18B2.27B1.85B1.96B
Net Income
2.28B2.76B2.00B2.07B1.61B1.50B
EPS
----0.360.33
EPS Growth
-----22.33%-7.64%
Forward PE
12.6317.4811.028.839.058.00
Dividend / Share
0.140.170.170.220.160.14
Dividend Growth
9.23%16.20%1.64%28.44%-27.16%-7.93%
Free Cash Flow
802.50M349.83M968.17M1.64B1.27B1.63B
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High13.9B
Avg13.8B
Low13.8B

Revenue Growth

Revenue Growth202620272028
High
3.5%
Avg
3.1%
Low
2.9%

EPS Forecast

EPS202620272028
High0.35
Avg0.33
Low0.30

EPS Growth

EPS Growth202620272028
High
-2.0%
Avg
-7.6%
Low
-16.0%